Back to comparisons

Comparison

Rhodiola Rosea vs He Shou Wu (Fo-Ti)

FieldRhodiola RoseaHe Shou Wu (Fo-Ti)
Categoryadaptogenadaptogen
Dose range200–400mg500–2000mg
Half-life4h
Onset
EvidenceEVIDENCEAEVIDENCEC
Safety●●●●●●●○○○
Legal (US)USOTCUSOTC
PubMed refs460400

The comparison in plain English

Auto-generated from data

Rhodiola Rosea and He Shou Wu (Fo-Ti) are both in the adaptogen category respectively. Rhodiola Rosea An Arctic adaptogen used for centuries in Siberian, Scandinavian, and Tibetan traditional medicine. He Shou Wu (Fo-Ti) Chinese herb (Polygonum multiflorum) traditionally used for longevity and hair pigmentation.

Bottom line

Rhodiola Rosea (evidence A, safety 5/5) has a weaker evidence base than He Shou Wu (Fo-Ti) (evidence C, safety 2/5). Rhodiola Rosea has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Rhodiola Rosea if

Rhodiola Rosea is the better fit when your goal aligns with its mechanism (Rosavins and salidroside (the two standardised active compounds) modulate the HPA axis cortisol response under acute stress) and the dose range (200–400mg) suits your protocol. Half-life is 4h.

Choose He Shou Wu (Fo-Ti) if

He Shou Wu (Fo-Ti) is the better fit when your goal aligns with its mechanism (Anthraquinones, stilbenes, and phospholipids contribute to antioxidant and lipid-lowering effects) and the dose range (500–2000mg) suits your protocol. Half-life is —h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →